Skip to main content

Year: 2022

Update: Emmy Award-Winning Journalist, Documentary Film Producer, and Tech Executive, Amber Theoharis, Joins RAADR as Chief Brand Ambassador for Its Anti-Bullying and Parental Monitoring Application Launch

RAADR Amber TheoharisPhoenix, AZ, Dec. 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —   RAADR, Inc. (OTC PINK: RDARD), a technology and software development company that provides cutting edge solutions for cyber-bullying on social media platforms, announced today that it has executed an agreement with Emmy Award-winning journalist, documentary film producer, and tech executive Amber Theoharis as Chief Brand Ambassador. The veteran media-personality will be instrumental in the development and marketing of the soon-to-launch RAADR App. Theoharis is best known for her on-air work on NFL Network, Fox Sports, FS1, Raiders Gameday, Sirius XM and The NFL on Westwood One. In addition to her 20-year, award-winning television career, Amber is a writer, producer, and educator. She co-executive produced the HBO documentary The Weight...

Continue reading

Diana Shipping Inc. Announces Delivery of the Ultramax Dry Bulk Vessel m/v DSI Altair and Her Entry Into Time Charter Contract With Western Bulk; A Time Charter Contract for m/v Ismene With ST Shipping

ATHENS, Greece, Dec. 27, 2022 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has taken delivery of the m/v DSI Altair (formerly “STH Sydney”), a 2016 built Ultramax dry bulk vessel of 60,309 dwt. The vessel is one of nine modern Ultramax dry bulk vessels that the Company entered into an agreement to purchase in August 2022. The Company also announced that, through the same wholly-owned subsidiary, it entered into a time charter contract with Western Bulk Pte. Ltd. at a gross charter rate of US$14,400 per day, minus a 5.0% commission paid to third parties, for a period until minimum June 25, 2023 up to maximum August 25, 2023. The charter is...

Continue reading

Del Taco Celebrates “The Last Great Value Menu” With 20 Twenty Free Program All Month Long in January

Del Taco’s 20 Under $2 menu items Del Taco is ringing in the New Year by celebrating their everyday affordable “20 Under $2” Menu with their guestsLAKE FOREST, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) — Del Taco, the nation’s second largest Mexican quick service restaurant*, is ringing in the New Year by celebrating their everyday affordable “20 Under $2” Menu with their guests. Arguably the last great value menu in the quick service category, Del Taco will be giving Del Yeah!™ Rewards members one free select “20 Under $2” Menu** item every day in January with any $3 purchase*** with their 20 Twenty Free Program. To access program offers guests must download the Del Taco App. The 20 Twenty Free program allows Del Yeah!™ Rewards members to try the huge variety of everyday affordable menu items on the “20 Under...

Continue reading

Five Below, Inc. Announces Participation in the 2023 ICR Conference

PHILADELPHIA, PA, Dec. 27, 2022 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that management will participate in the 2023 ICR Conference to be held at the JW Marriott Orlando Grande Lakes in Orlando, Florida. Joel Anderson, President and CEO, and Ken Bull, CFO, are currently scheduled to participate in a fireside chat on Monday, January 9, 2023 at 10:00 a.m. Eastern Time. The audio portion of the fireside chat will be webcast live at http://investor.fivebelow.com/. An archived replay will be available two hours after the conclusion of the live event. The company plans to release its holiday sales results prior to the ICR Conference. About Five Below: Five Below is a leading high-growth value retailer offering trend-right, high-quality...

Continue reading

Smart for Life Announces Launch of Greens First Protein Bars

New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super Foods, Expected Launch in Q1 2023Smart for Life Launches Greens First Protein Bars Smart for Life Launches Greens First Protein BarsMIAMI, Dec. 27, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it is launching a line of Greens First protein bars, specifically created with the flagship Greens First PRO formula. Greens First protein bars represent a brand new premium nutritious protein bar, combined with the Greens First PRO powder, which is fortified with whole plants, vegetables and...

Continue reading

Aspira Women’s Health Announces Three Reimbursement Milestones that Improve Patient Access to its OvaSuite SM Testing Portfolio

Expanded Medicare coverage for multi-marker testing, including Ova1Plus® and OvaWatchSM, through the 2023 Omnibus Spending Bill Granted a new PLA Code for OvaWatch by the American Medical Association Expanded Medicaid coverage adding another 5 states: Virginia, Alabama, Maine, Pennsylvania, and Rhode Island AUSTIN, Texas, Dec. 27, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced that the 2023 Omnibus Spending Bill passed by Congress and awaiting President Biden’s signature contains language directing the Center for Medicare & Medicaid Services (CMS) to cover multi-marker tests for ovarian cancer. The company believes all of its commercially available ovarian cancer risk assessment blood tests would fall under the recommended...

Continue reading

Rain Therapeutics to Participate in the 41st Annual J.P. Morgan Health Care Conference

NEWARK, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today announced that it will be participating in J.P. Morgan’s 41st Annual Health Care Conference, being held January 9 – 12, 2023, in San Francisco, CA. Avanish Vellanki, chief executive officer of Rain, will be presenting a corporate overview on Wednesday, January 11, 2023 at 9:00 a.m. PT. An audio of the presentation can be accessed here. The Company’s management team will participate in one-on-one investor meetings. About Rain Therapeutics Inc. Rain Therapeutics Inc. is a late-stage precision oncology company developing therapies...

Continue reading

ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement

SINGAPORE, Dec. 27, 2022 (GLOBE NEWSWIRE) — ALR Technologies SG Ltd. (“ALRT”) (OTCQB:ALRTF), the diabetes management company, today announced the completion of a long-term manufacturing and supply agreement with Infinovo Medical Co. Ltd (“Infinovo”) for the Continuous Glucose Monitor (CGM) hardware used in the GluCurve Pet CGM. The agreement gives ALRT the exclusive global rights to distribute the CGM hardware in the animal health market. Additionally, the Company announces it anticipates December and fourth quarter of 2022 sales to be in the range of $145,000 and $155,000. The Company expects Q1 2023 sales to be in the range of $450,000 to $600,000 with the possibility of an adjustment upwards subject to increased production capacity. “December reflects a turning point for ALRT as we look to close out the fiscal year with our...

Continue reading

Family Care Center with Eight Locations Selected Zerify Meet to Protect Patient Data

EDISON, N.J., Dec. 27, 2022 (GLOBE NEWSWIRE) — Zerify Inc., (OTCQB: ZRFY), the 21-year-old cybersecurity company focused on secure video conferencing solutions, today announced that a private, non-profit family care center with eight locations has licensed Zerify Meet to protect patient data. “Healthcare organizations have become a favorite target of cybercriminals who target patient records,” says Mark L. Kay, CEO of Zerify. “Zerify Meet is the healthcare industry’s only HIPAA compliant video conferencing platform built with a ‘Zero Trust’ architecture to keep patient data secure.” “The Health Insurance Portability and Accountability Act of 1996 (HIPAA) is a federal law that created a set of national standards to protect sensitive patient health information from being disclosed without a patient’s consent and knowledge,”...

Continue reading

P10 Announces Increase to Stock Buyback Program

DALLAS, Dec. 27, 2022 (GLOBE NEWSWIRE) — P10, Inc. (“P10”) (NYSE: PX), a leading private markets solutions provider, today announced that its Board of Directors has authorized an increase to its stock buyback program pursuant to which P10 may purchase up to an additional $20 million of P10’s outstanding shares of Class A and Class B Common Stock, par value $0.001 per share. P10 intends to fund the program through available cash balances, the Company’s existing credit facility, and future operating cash flows. These shares may be repurchased from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades, in accordance with Rule 10b5-1 trading plans and/or through other legally permissible means. The timing and amount of any repurchases pursuant to the program will depend on...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.